文章核心观点 - 公司推出了首创性的Q Guidance System with Spine Guidance 5 Software featuring Copilot技术 [1][2][3] - 该技术集成了智能化手术器械,为脊柱手术提供多种反馈模式,以提高外科医生的手术效率和患者结果 [4][6] - 公司与850多名脊柱外科医生合作开发了这项技术 [4] - 该技术是公司创新发展的一个典型案例,体现了公司倾听客户需求并与医生合作的理念 [5] - 公司表示这只是其创新管线的开始,未来将继续专注于植入物、手术器械和辅助技术的创新与整合 [7] 公司信息 - 公司是全球医疗技术领导者,致力于为客户提供创新产品和服务,以改善患者和医疗结果 [10] - 公司产品涵盖医疗外科、神经技术、骨科和脊柱等领域 [10] - 公司每年影响全球超过1.5亿患者 [10] 商业动态 - 公司新产品Q Guidance System with Spine Guidance 5 Software featuring Copilot获得FDA 510(k)认证 [2] - 该产品将于9月开始进行首次临床应用,预计在今年秋季正式商业化推出 [8]

文章核心观点 - 分析师预计Stryker公司将在即将公布的季度财报中宣布每股收益2.79美元,同比增长9.8%[1] - 收入预计将达到54.1亿美元,同比增长8.2%[1] - 分析师对该季度的盈利预测在过去30天内保持不变,反映了分析师对公司业绩的整体评估[2] 按目录分类总结 业务板块 - 骨科和脊柱业务收入预计为22.9亿美元,同比增长7.1%[6] - 医疗器械和神经技术业务收入预计为31.2亿美元,同比增长9%[7] - 骨科和脊柱-膝关节业务收入预计为6.0023亿美元,同比增长6.8%[8] - 骨科和脊柱-脊柱业务收入预计为3.1538亿美元,同比增长6.6%[9] 地区分布 - 美国市场收入预计为39.8亿美元,同比增长7.3%[10] - 国际市场收入预计为13.9亿美元,同比增长8.1%[11] - 骨科和脊柱-创伤和四肢-美国市场收入预计为6.0296亿美元,同比增长7.9%[11] - 骨科和脊柱-膝关节-美国市场收入预计为4.2927亿美元,同比增长5.7%[12] - 骨科和脊柱-髋关节-美国市场收入预计为2.6418亿美元,同比增长6.1%[13] - 骨科和脊柱-创伤和四肢-国际市场收入预计为2.1934亿美元,同比增长6%[14] - 骨科和脊柱-髋关节-国际市场收入预计为1.5028亿美元,同比增长4.4%[14] - 骨科和脊柱-膝关节-国际市场收入预计为1.652亿美元,同比增长5.9%[14]

文章核心观点 - 该公司完成了对Artelon公司的收购,Artelon专注于创新的软组织固定产品,此次收购有助于公司在软组织固定领域的产品线扩展 [1][2][3][4] - 公司近年来通过收购多家公司来增强自身在神经血管、数字护理协调、关节置换等领域的产品线和技术实力 [5][6][7] - 公司收购策略旨在提升自身在相关领域的市场地位和领导地位 [8] 行业概况 - 根据Mordor Intelligence的报告,全球软组织修复市场预计将从2024年的148亿美元增长到2029年的188亿美元,年复合增长率为4.9% [9] - 运动相关伤害的发生率上升是推动该市场增长的主要因素之一 [10] - 公司收购Artelon有望提升其在该市场的业务和收入 [11] 公司近期动态 - 2024年5月,公司宣布在欧洲成功完成首例使用Infinity Total Ankle System with Adaptis和Everlast技术的手术 [12] - 2023年2月,公司宣布在欧洲成功完成首例使用Blueprint Mixed Reality (MR) Guidance System进行肩关节置换手术 [13] 股价表现 - 年初至今,公司股价上涨9.7%,同期行业上涨2.3%,标普500指数上涨17% [14] - 公司目前评级为买入评级 [15]

Stryker Corporation (SYK) witnessed substantial gains in the year-to-date period. Shares of the company have rallied 11.6% compared with 1.7% growth of the industry. The S&P 500 Composite has risen 17.5% during the same time frame.With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) company appears to be a solid wealth creator for its investors at the moment.Headquartered in Kalamazoo, MI, Stryker is one of the world’s largest medical device companies operating in the global o ...

Portage, Michigan, July 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, July 30, 2024. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s second quarter of fiscal year 2024, that ended June 30, 2024. Stryker will host a webcast at 4:30pm ET on Tuesday, July 30, to discuss res ...

PORTAGE, Michigan and CHARLOTTE, North Carolina, USA, June 18, 2024 /PRNewswire/ -- Stryker is bringing its innovative products, platforms and robotic technologies to IRCAD North America (IRCAD NA), a subsidiary of Atrium Health, as part of a multi-year agreement supporting the creation of a cutting-edge experiential education center in Charlotte, North Carolina. IRCAD NA is set to become the cornerstone of the first research building at "The Pearl," a new innovation district currently under construction in ...

文章核心观点 - 公司最新推出了LIFEPAK 35监护除颤仪,该设备采用先进技术,提高了患者护理效率 [1][2][4][5] - 该设备为急救人员和医疗专业人员提供实时访问患者关键数据的能力,满足他们的需求并改善患者护理 [2][5] - 公司还推出了其他一系列连接数字解决方案,如1688 AIM 4K平台和Blueprint 3D规划及混合现实系统,旨在提供更好的患者护理并提高工作流程 [7][8][9] - 全球急诊室分诊市场预计将从2023年的31亿美元增长到2030年的62.7亿美元,增长率为10.6%,为公司LIFEPAK 35设备带来良好的市场前景 [10][11][12] 公司相关 - 公司最新推出的LIFEPAK 35监护除颤仪采用先进技术,提高了患者护理效率 [1][2][4][5] - 公司还推出了其他一系列连接数字解决方案,如1688 AIM 4K平台和Blueprint 3D规划及混合现实系统,旨在提供更好的患者护理并提高工作流程 [7][8][9] - 公司最近完成了Infinity Total Ankle System和Blueprint Mixed Reality Guidance System在欧洲的首次手术 [13][14] 行业相关 - 全球急诊室分诊市场预计将从2023年的31亿美元增长到2030年的62.7亿美元,增长率为10.6%,为公司LIFEPAK 35设备带来良好的市场前景 [10][11][12] - 市场增长主要由创伤伤害和医疗急症事件的增加以及老龄人口患慢性疾病的增加所推动 [11]

LIFEPAK 35, a clinically advanced monitor/defibrillator, reduces caregiver burden and streamlines workflow.1 PORTAGE, Mich., USA, June 4, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of LIFEPAK 35 monitor/defibrillator, the latest product in the monitor/defibrillator space, offering advanced technology and built on an intuitive1, modern platform to help advance patient care. LIFEPAK 35 Monitor/DefibrillatorLIFEPAK 35 Monitor/Defibrillator Emergency r ...

Stryker Corporation (SYK) recently initiated a voluntary correction for the application software in the Mako Total Knee system. The company issued an urgent field safety notice due to increased software error #3 code. The error code is reflected when a Mako system shutdown or restart is not performed before switching between total knee and total hip applications. Per the company, the potential harms of this issue are complications associated with extended surgery. Price Performance For the past six months, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-13149 STRYKER CORPORATION (Exact name of registrant as specified in its charter) Michigan 38-1239739 (State of incorporation) (I.R.S. Employer Identification No.) 1941 Stry ...